Physician profile
Allen Gu
NPI 1750822185
$5,637.75
in general payments reported to CMS, 2019-2025
18 companies · $2,600 in 2025
The $2,600 reported for 2025 was more than what 90% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $242 · 2022: $542 · 2023: $1,119 · 2024: $1,136 · 2025: $2,600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,004 · Consulting Fee: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,004.46 |
| Consulting Fee | $850.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,465.69 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,093.50 | 2022-2025 | Eylea Hd, Eylea |
| Genentech USA, INC. | $699.60 | 2024-2025 | Vabysmo, Susvimo |
| Bausch & Lomb Americas INC. | $494.18 | 2024-2025 | Xipere, Stellaris, Stellaris |
| Alcon Vision LLC | $325.17 | 2023-2025 | Constellation, Clareon Panoptix Pro, Unity |
| Astellas Pharma US INC | $232.63 | 2025 | Izervay |
| Regeneron Pharmaceuticals, INC. | $212.95 | 2022-2025 | Eylea, Eylea Hd |
| Carl Zeiss Meditec USA, INC. | $205.17 | 2025 | Callisto Eye |
| Glaukos Corporation | $131.76 | 2025 | Idosetr |
| Apellis Pharmaceuticals, INC. | $124.99 | 2024 | Syfovre |
| Dompe US, INC. | $95.30 | 2025 | Oxervate |
| Genentech, INC. | $78.71 | 2022 | |
| Ani Pharmaceuticals, INC. | $74.29 | 2025 | Purified Cortrophin Gel, Iluvien, Yutiq |
| Dutch Ophthalmic, USA | $61.85 | 2024 | Tissueblue, Eva, Combined Machine |
| Alimera Sciences, INC. | $40.06 | 2024 | Yutiq, Iluvien |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurotech Pharmaceuticals, INC. | $25.08 | 2025 | |
| Harrow Eye, LLC | $22.34 | 2025 | Triesence |
| Horizon Therapeutics Plc | $12.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Gu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.